Histogen Obtains New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=b69d2cf5-ec52-4598-a174-a52e98741ddb - Date
8/11/2015 - Company Name
Histogen - Mailing Address
10655 Sorrento Valley Road San Diego, CA 92121 USA - Company Description
Histogen, launched in 2007, seeks to redefine regenerative medicine by developing a series of high value products without the use of embryonic stem cells or animal products. Histogen has two product families – Exceltrix, Histogen’s human Extracellular Matrix (ECM) and HGEN-001, Histogen’s proprietary liquid formula. - Website
http://www.histogeninc.com - Transaction Type
Venture Equity - Transaction Amount
Undisclosed - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities. - M&A Terms
- Venture Investor
Undisclosed
